Authors: KIEL K CREMER F ATZBERGER A GOLDSCHMIDT H MOOS M

Citation: K. Kiel et al., CD19(-CELLS AFTER HIGH-DOSE-THERAPY AND PERIPHERAL-BLOOD PROGENITOR-CELL TRANSPLANTATION IN PATIENTS WITH MULTIPLE-MYELOMA() CELLS CONTAIN ONLY A MINOR FRACTION OF MALIGNANT), Blood, 88(10), 1996, pp. 1565-1565

Authors: GOLDSCHMIDT H HEGENBART U CREMER F KIEL K WALLMEIER M HOHAUS S HAAS R MOOS M

Citation: H. Goldschmidt et al., PBPC MOBILIZATION IN MULTIPLE-MYELOMA - HIGH-DOSE CHEMOTHERAPY PLUS G-CSF VS 2 DIFFERENT DOSAGES OF G-CSF DURING STEADY-STATE, Blood, 88(10), 1996, pp. 1610-1610

Authors: MOOS M SCHULZ R CREMER F SUCKER C SCHMOHL D DOHNER H GOLDSCHMIDT H HAAS R HUNSTEIN W

Citation: M. Moos et al., DETECTION OF MINIMAL RESIDUAL DISEASE BY POLYMERASE CHAIN-REACTION INB-CELL MALIGNANCIES, Stem cells, 13, 1995, pp. 42-51

Authors: GOLDSCHMIDT H MOOS M CREMER F ATZBERGER A WITT B HAAS R HUNSTEIN W

Citation: H. Goldschmidt et al., ANTIGENIC PROFILE AND PCR ANALYSIS OF PERIPHERAL-BLOOD PROGENITOR-CELL AUTOGRAFTS IN MULTIPLE-MYELOMA, Blood, 84(10), 1994, pp. 10000385-10000385